サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663514

生物製剤用添加剤の世界市場：種類別・原料別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Biologic Excipients Market, By Product, By Source, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
生物製剤用添加剤の世界市場：種類別・原料別・用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年01月04日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

生物製剤用添加剤の市場規模は2024年に29億8,343万米ドルとなり、2025年から2032年にかけてCAGR 5.90%で拡大

生物製剤用添加剤の市場力学

生物製剤の需要増加

生物製剤は、がん、自己免疫疾患、希少遺伝子疾患などの複雑な疾患に対して、標的を絞った非常に効果的な治療を提供するため、生物製剤に対する需要の増加は、生物製剤用添加剤市場の成長における主要な促進要因です。モノクローナル抗体、ワクチン、細胞療法を含む生物製剤は、その複雑な分子構造と環境要因に対するより高い感受性を特徴としており、安定性、有効性、安全性を確保するために特殊な賦形剤の使用が不可欠となっています。この需要に拍車をかけているのが、世界の慢性疾患の有病率の上昇と、高度な治療ソリューションを必要とする老人人口の拡大です。世界保健機関 (WHO) によると、慢性疾患は世界の全死亡の約71%を占めており、革新的な生物製剤をベースとした治療に対する緊急の必要性が浮き彫りになっています。これを受けて、各国政府や医療機関は生物製剤の研究開発への投資を大幅に増やしています。例えば米国では、2023年の処方薬売上高上位100品目のうち生物製剤が50%近くを占め、市場支配力の高まりを反映しています。この動向生物製剤用添加剤市場に直接影響します。製造業者はドラッグの製剤化とデリバリーを強化するために高度な賦形剤ソリューションを必要としているからです。その結果、生物製剤用添加剤市場は、革新的な治療法の絶え間ない開発と厳しい規制・品質基準を満たす必要性によって、大きく成長する態勢を整えています。

生物製剤用添加剤市場：主な考察

  • 弊社のリサーチアナリストの分析によると、世界市場は予測期間 (2025-2032年) に約5.90%のCAGRで毎年成長すると推定されています。
  • 製品別では、安定剤が2024年に最大市場シェアを示すと予測されました。
  • 用途別では、2024年にバイオ医薬品製造が主要セグメントとなります。
  • 地域別では、北米が2024年に収益を上げる主要市場です。

生物製剤用添加剤市場：セグメンテーション分析

生物製剤用添加剤の世界市場は、製品、原料、用途、地域によって区分されます。

市場は製品によって5つのカテゴリーに分けられます：可溶化剤、安定剤、保存剤、緩衝剤、担体です。安定剤は、感受性の高い生物製剤に共通する問題であるタンパク質の凝集、酸化、変性を防ぐという重要な役割を担っているため、市場を独占しています。薬剤の安定性を高め、保存期間を延長する能力により、生物製剤に不可欠なものとなっています。

市場は用途によって3つのカテゴリーに分けられます：バイオ医薬品生産、研究開発、臨床試験です。バイオ医薬品製造は、最大かつ最も重要な用途分野であり、製造中の生物製剤の安定性、有効性、拡張性を確保するために特殊な賦形剤を必要とするため、市場を独占しています。革新的な生物学的治療に対する需要の高まりと大規模生産のニーズが、この分野における賦形剤の広範な使用を後押ししています。

生物製剤用添加剤市場：地域別分析

北米が市場を独占している主な理由は、製薬・バイオテクノロジー産業が確立していること、研究開発投資が活発であること、生物製剤を必要とする慢性疾患が増加していることです。大手製薬企業や高度な研究施設を擁する米国が大きな市場シェアを占めています。さらに、米国FDAによる生物製剤の迅速承認など、政府の積極的な取り組みや規制当局の支援が市場成長をさらに後押ししています。欧州は、強力なバイオ医薬品生産能力、医薬品開発における革新性、欧州医薬品庁 (EMA) のような機関による支援的な規制政策によって牽引されているもう一つの主要地域です。ドイツ、フランス、英国などの国々が、生物製剤の開発と生産でこの地域をリードしています。アジア太平洋は、医薬品製造部門の拡大、生物製剤の研究開発への投資の増加、医療費の増加により、最も速い成長が見込まれています。中国やインドなどの国々は、生物製剤の現地生産と輸出を促進するための政府の支援を受けており、主要なプレーヤーとして台頭してきています。先端療法に対する意識の高まりと製造受託機関 (CMO) の増加が地域の成長に寄与しています。

生物製剤用添加剤市場：競合情勢

生物製剤用添加剤市場は、継続的な技術革新、技術進歩、複雑な生物製剤に合わせた高品質で特殊な賦形剤への注目の高まりによって、激しい競争が特徴となっています。市場各社は、バイオ医薬品用途の厳しい規制基準を満たす安定剤、可溶化剤、保存剤を提供する製品ポートフォリオに基づいて競争しています。安定性特性と生体適合性を向上させた多機能賦形剤の開発は、市場シェアを獲得するための主な競争戦略です。賦形剤メーカーとバイオ医薬品企業とのパートナーシップ、共同研究、戦略的提携は一般的であり、カスタマイズされたソリューションと共同イノベーションを可能にしています。さらに、生物製剤製造のアウトソーシング動向の高まりは、医薬品開発・製造受託機関 (CROおよびCMO) に成長機会をもたらし、市場ダイナミクスを激化させています。企業はまた、アジア太平洋を中心とする新興市場の急成長を取り込むため、地理的プレゼンスの拡大にも注力しています。規制当局の圧力や環境問題への懸念に後押しされ、環境に配慮した持続可能な賦形剤製造におけるイノベーションが、差別化の重要な要素になりつつあります。さらに、先進的な研究施設への投資と、進化する規制ガイドラインの遵守が、競争上のポジショニングを高めています。

目次

第1章 生物製剤用添加剤市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 生物製剤用添加剤の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 生物製剤用添加剤市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 生物製剤用添加剤市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 生物製剤用添加剤の市場情勢

  • 生物製剤用添加剤の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 生物製剤用添加剤市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 可溶化剤
    • 安定剤
    • 防腐剤
    • 緩衝剤
    • 担体
    • その他

第8章 生物製剤用添加剤市場：原料別

  • 概要
    • セグメント別シェア分析：原料別
    • 動物由来
    • ヒト由来
    • 微生物由来
    • 合成

第9章 生物製剤用添加剤市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • バイオ医薬品製造
    • 研究開発
    • 臨床試験

第10章 生物製剤用添加剤市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • オランダ
    • スウェーデン
    • ロシア
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • インドネシア
    • タイ
    • フィリピン
    • その他
  • ラテンアメリカ (LATAM)
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ (MEA)
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：生物製剤用添加剤業界

  • 競合ダッシュボード
    • 競合ベンチマーク
    • 競合ポジショニング
  • 企業プロファイル
    • Dow Chemical Company
    • BASF SE
    • Evonik Industries AG
    • Lonza Group
    • Wacker Chemie AG
    • Asahi Kasei Corporation
    • Clariant International Ltd.
    • Croda International Plc
    • Ingredion Incorporated
    • Fuji Chemical Industry Co. Ltd.
    • Nippon Fine Chemical Co. Ltd.
    • DSM Nutritional Products
    • Protex International
    • Lubrizol Corporation
    • Ashland Global Holdings Inc.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4716

REPORT HIGHLIGHT

Biologic Excipients Market size was valued at US$ 2,983.43 Million in 2024, expanding at a CAGR of 5.90% from 2025 to 2032.

Biologic Excipients are non-active components used in the formulation of biologic drugs to enhance their stability, solubility, and overall performance. Unlike active pharmaceutical ingredients (APIs), these excipients do not produce therapeutic effects but play a critical role in ensuring the efficacy, safety, and shelf-life of biologic products. Given the sensitive nature of biologics such as proteins, peptides, and monoclonal antibodies, the selection of appropriate excipients is crucial in overcoming challenges related to stability, degradation, and delivery. The need for biologic excipients arises from the complex and fragile structure of biological molecules, which are highly susceptible to environmental factors like heat, light, and pH changes. Excipients act as stabilizers to prevent protein aggregation, oxidation, or denaturation, thus preserving the drug's potency. Additionally, solubilizers and surfactants improve the solubility of poorly soluble compounds, enhancing their bioavailability and therapeutic effectiveness. Preservatives and buffering agents are essential for maintaining product sterility and pH balance, ensuring safe administration to patients. The importance of biologic excipients lies in their ability to optimize drug formulation, support large-scale production, and extend shelf-life without compromising product quality. Their proper use enhances patient outcomes, regulatory compliance, and the commercial success of biologic therapies in modern medicine.

Biologic Excipients Market- Market Dynamics

Increasing demand for biologic drugs

The increasing demand for biologic drugs is a key driver in the growth of the biologic excipients market, as biologics offer targeted, highly effective treatments for complex diseases such as cancer, autoimmune disorders, and rare genetic conditions. Biologic drugs, including monoclonal antibodies, vaccines, and cell therapies, are characterized by their complex molecular structures and greater sensitivity to environmental factors, making the use of specialized excipients essential to ensure stability, efficacy, and safety. This demand is fueled by the rising prevalence of chronic diseases globally and the expanding geriatric population requiring advanced therapeutic solutions. According to the World Health Organization (WHO), chronic diseases account for approximately 71% of all deaths worldwide, highlighting the urgent need for innovative biologic-based treatments. In response, governments and healthcare organizations are significantly increasing investments in biologic drug research and development. For instance, in the United States, biologics accounted for nearly 50% of the top 100 prescription drug sales in 2023, reflecting their growing market dominance. This trend directly impacts the biologic excipients market, as manufacturers require sophisticated excipient solutions to enhance drug formulation and delivery. As a result, the biologic excipients market is poised for significant growth, driven by the continuous development of innovative therapies and the need to meet stringent regulatory and quality standards.

Biologic Excipients Market- Key Insights

  • As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2025-2032)
  • Based on Product segmentation, Stabilizers was predicted to show maximum market share in the year 2024
  • Based on Application segmentation, Biopharmaceutical Production was the leading segment in 2024
  • On the basis of region, North America was the leading revenue generator in 2024

Biologic Excipients Market- Segmentation Analysis:

The Global Biologic Excipients Market is segmented on the basis of Product, Source, Application and Region.

The market is divided into five categories based on Product: Solubilizers, Stabilizers, Preservatives, Buffers and Carriers. Stabilizers dominate the market due to their critical role in preventing protein aggregation, oxidation, and denaturation, which are common issues with sensitive biologic drugs. Their ability to enhance drug stability and extend shelf life makes them indispensable in biologic formulations.

The market is divided into three categories based on Application: Biopharmaceutical Production, Research and Development and Clinical Trials. Biopharmaceutical Production dominates the market because it represents the largest and most critical application segment, requiring specialized excipients to ensure the stability, efficacy, and scalability of biologic drugs during manufacturing. The growing demand for innovative biologic therapies and large-scale production needs drives the extensive use of excipients in this sector.

Biologic Excipients Market- Geographical Insights

North America dominates the market, primarily due to its well-established pharmaceutical and biotechnology industries, extensive R&D investments, and the rising prevalence of chronic diseases requiring biologic therapies. The United States, with major players and advanced research facilities, accounts for a significant market share. Additionally, favorable government initiatives and regulatory support, such as the U.S. FDA's fast-track approvals for biologics, further boost market growth. Europe represents another major region, driven by strong biopharmaceutical production capabilities, innovation in drug development, and supportive regulatory policies from agencies like the European Medicines Agency (EMA). Countries like Germany, France, and the UK lead the region in biologic drug development and production. The Asia-Pacific region is expected to witness the fastest growth due to the expanding pharmaceutical manufacturing sector, increasing investments in biologic R&D, and growing healthcare expenditures. Countries such as China and India are emerging as key players, with government-backed initiatives to boost local biologic production and exports. Rising awareness about advanced therapies and an increasing number of contract manufacturing organizations (CMOs) contribute to regional growth.

Biologic Excipients Market- Competitive Landscape:

The Biologic Excipients Market is characterized by intense competition driven by continuous innovation, technological advancements, and a growing focus on high-quality, specialized excipients tailored for complex biologic formulations. Market players compete based on product portfolios, offering stabilizers, solubilizers, and preservatives that meet stringent regulatory standards for biopharmaceutical applications. The development of multifunctional excipients with enhanced stability properties and improved biocompatibility is a key competitive strategy to gain market share. Partnerships, collaborations, and strategic alliances between excipient producers and biopharmaceutical companies are common, enabling customized solutions and joint innovation. Additionally, the rising trend of outsourcing biologic drug manufacturing has created growth opportunities for contract research and manufacturing organizations (CROs and CMOs), intensifying market dynamics. Companies are also focusing on expanding their geographic presence to capitalize on the rapid growth in emerging markets, especially in Asia-Pacific. Innovation in green and sustainable excipient production, driven by regulatory pressures and environmental concerns, is becoming a critical differentiator. Furthermore, investments in advanced research facilities and adherence to evolving regulatory guidelines enhance competitive positioning.

Recent Developments:

  • In July 2024, Agilent Technologies Inc. announced a definitive agreement to acquire BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO), for $925 million. This strategic acquisition aims to expand Agilent's biopharma solutions by incorporating BIOVECTRA's expertise in biologics, highly potent active pharmaceutical ingredients, and other targeted therapeutic molecules.
  • In November 2024, Clariant introduced a range of high-performance excipients at CPHI India 2024 to address the growing needs of the Indian healthcare market. These excipients are designed for sensitive active pharmaceutical ingredients (APIs), parenteral formulations, and colorless applications, with an emphasis on purity and bioavailability. The company is leveraging India's manufacturing capabilities to deliver customized solutions that meet global regulatory standards, ensuring the efficacy and safety of biologics and complex drug formulations.
  • In October 2024, Samsung Biologics launched a high-concentration formulation platform aimed at advancing the development of high-dose biologic drugs. This platform is designed to improve the delivery and efficacy of drugs with higher concentrations, streamlining the development process and meeting the increasing demand for such therapies. It supports both the manufacturing and formulation of biologics, ensuring better stability and scalability.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOLOGIC EXCIPIENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Dow Chemical Company
  • BASF SE
  • Evonik Industries AG
  • Lonza Group
  • Wacker Chemie AG
  • Asahi Kasei Corporation
  • Clariant International Ltd.
  • Croda International Plc
  • Ingredion Incorporated
  • Fuji Chemical Industry Co. Ltd.
  • Nippon Fine Chemical Co. Ltd.
  • DSM Nutritional Products
  • Protex International
  • Lubrizol Corporation
  • Ashland Global Holdings Inc.
  • Others

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Solubilizers
  • Stabilizers
  • Preservatives
  • Buffers
  • Carriers
  • Others

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY SOURCE - MARKET ANALYSIS, 2019 - 2032

  • Animal-derived
  • Human-derived
  • Microbial-derived
  • Synthetic

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Biopharmaceutical Production
  • Research and Development
  • Clinical Trials

GLOBAL BIOLOGIC EXCIPIENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Biologic Excipients Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Biologic Excipients Market Snippet by Product
    • 2.1.2. Biologic Excipients Market Snippet by Source
    • 2.1.3. Biologic Excipients Market Snippet by Application
    • 2.1.4. Biologic Excipients Market Snippet by Country
    • 2.1.5. Biologic Excipients Market Snippet by Region
  • 2.2. Competitive Insights

3. Biologic Excipients Key Market Trends

  • 3.1. Biologic Excipients Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Biologic Excipients Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Biologic Excipients Market Opportunities
  • 3.4. Biologic Excipients Market Future Trends

4. Biologic Excipients Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Biologic Excipients Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Biologic Excipients Market Landscape

  • 6.1. Biologic Excipients Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Biologic Excipients Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Solubilizers
    • 7.1.3. Stabilizers
    • 7.1.4. Preservatives
    • 7.1.5. Buffers
    • 7.1.6. Carriers
    • 7.1.7. Others

8. Biologic Excipients Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2024 & 2032 (%)
    • 8.1.2. Animal-derived
    • 8.1.3. Human-derived
    • 8.1.4. Microbial-derived
    • 8.1.5. Synthetic

9. Biologic Excipients Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Biopharmaceutical Production
    • 9.1.3. Research and Development
    • 9.1.4. Clinical Trials

10. Biologic Excipients Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Biologic Excipients Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Biologic Excipients Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Biologic Excipients Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Biologic Excipients Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Biologic Excipients Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Biologic Excipients Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Dow Chemical Company
    • 11.2.2. BASF SE
    • 11.2.3. Evonik Industries AG
    • 11.2.4. Lonza Group
    • 11.2.5. Wacker Chemie AG
    • 11.2.6. Asahi Kasei Corporation
    • 11.2.7. Clariant International Ltd.
    • 11.2.8. Croda International Plc
    • 11.2.9. Ingredion Incorporated
    • 11.2.10. Fuji Chemical Industry Co. Ltd.
    • 11.2.11. Nippon Fine Chemical Co. Ltd.
    • 11.2.12. DSM Nutritional Products
    • 11.2.13. Protex International
    • 11.2.14. Lubrizol Corporation
    • 11.2.15. Ashland Global Holdings Inc.
    • 11.2.16. Others

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us